Skip to main content Skip to main navigation menu Skip to site footer

Effectiveness of sclerotherapy injection in haemangioma of the head and neck region

  • Rizki Baihaqi ,
  • Marjono Dwi Wibowo ,


Link of Video Abstract:


Background: Hemangiomas are benign tumors that originate from blood vessels. Sclerotherapy effectively treats benign vascular lesions, especially small lesions located at sites with aesthetic impact. Polidocanol is the solution most commonly known to work by causing a local inflammatory reaction, thrombosis obliteration of the hemangiomatous space, and fibrosis of the endothelial space, leading to the lesion's regression. This study evaluated the effectiveness of polidocanol sclerotherapy injection therapy (Aethoxysklerol 3%) in patients with cavernous haemangioma at Dr. Soetomo general hospital.

Method: This study is a cross-sectional correlative analysis study, with research samples derived from medical records of patients with cavernous type haemangioma who were indicated to undergo sclerotherapy injection therapy (Aethoxysklerol 3%) at Dr. Soetomo general hospital in the period 2017-2023 who met the inclusion and exclusion criteria. The data obtained will be processed using SPSS software version 25.0 for Windows. Statistical tests were significant if the p-value was <0.05.

Results: There were 26 samples in this study, with the gender of patients mostly female (65.4%) and aged >20 years (38.5%). The most common location was buccal region hemangioma (34.2%). The results of the therapeutic response showed that 50% of the majority of patients not well responded, 34,2% showed no response, and only 15.4% responded well with a p-value = 0.000.

Conclusion: Injection sclerotherapy using polidocanol (Aethoxysklerol) in 3x administration sessions is a treatment method that has not been effective in treating hemangioma.


  1. Couto JA, Greene AK. Management of problematic infantile hemangioma using intralesional triamcinolone: Efficacy and safety in 100 infants. J Plast Reconstr Aesthetic Surg. 2014;67(11). doi: 10.1016/j.bjps.2014.07.009
  2. Crişan B, Băciuţ M, Băciuţ G, Crişan L, Bran S, Rotar H, et al. Laser therapy and sclerotherapy in the treatment of oral and maxillofacial hemangioma and vascular malformations. In: Sixth International Conference on Lasers in Medicine. 2016. doi: 10.1117/12.2185399
  3. Ademi Abdyli R, Abdyli Y, Perjuci F, Gashi A, Agani Z, Ahmedi J. Sclerotherapy of Intraoral Superficial Hemangioma. Case Rep Dent. 2016;2016. doi: 10.1155/2016/4320102
  4. Azadarmaki R, Then MT, Walia R, Lango MN. Cavernous hemangioma of the submandibular gland with parapharyngeal extension in an adult: Case report. Ear, Nose Throat J. 2016;95(2). doi: 10.1177/014556131609500204
  5. Yuliawati P, Rian-Ananta. Intralesional Triamcinolone Acetonide Injection On Eyelid Capillary Hemangioma (Case Report). Bali Med J 2013. 2013;2(3).
  6. Chaurasia DI, Shah DD, Chakrabarty DH, Rizvi DA, Butoliya DP, Arya DS, et al. Prevalence Of Tongue Hemangiomas In Western Rajasthan, A Cross- Sectional Study. J Pharm Negat Results. 2022;13(6):4089–92.
  7. Takaishi S, Asaka D, Nakayama T, Iimura J, Matsuwaki Y, Hirooka S, et al. Features of sinonasal hemangioma: A retrospective study of 31 cases. Auris Nasus Larynx. 2017;44(6). doi: 10.1016/j.anl.2017.01.012
  8. Sangma R, Patar M. Role of Polidocanol as Sclerosant in Treatment of Hemangiomas of Head and Neck Region. Bengal J Otolaryngol Head Neck Surg. 2017;25(3). doi: 10.47210/bjohns.2017.v25i3.136
  9. Agarwal S. Treatment of Oral Hemangioma with 3% Sodium Tetradecyl Sulfate: Study of 20 Cases. Indian J Otolaryngol Head Neck Surg. 2012;64(3). doi: 10.1007/s12070-011-0249-z
  10. Bhadoria S, Saxena R, Lavania A. Management of haemangioma neck using sclerosing agent- a case report. J Coll Med Sci. 2012;8(1). doi: 10.3126/jcmsn.v8i1.6828
  11. Singh R, Agarwal SP, Sinha ON, Gaur S. A Case Report - Inj Polidocanol in Haemangioma of Tongue. Sch J Appl Med Sci. 2016;4:2433–5. doi: 10.36347/sjams.2016.v04i07.027

How to Cite

Baihaqi, R., & Wibowo, M. D. . (2023). Effectiveness of sclerotherapy injection in haemangioma of the head and neck region. Bali Medical Journal, 12(3), 3220–3222.




Search Panel